Samrat Pharmachem standalone net profit rises 717.65% in the December 2024 quarter
Net profit of Samrat Pharmachem rose 717.65% to Rs 2.78 crore in the quarter ended December 2024 as against Rs 0.34 crore during the previous quarter ended December 2023. Sales rose 3.23% to Rs 63.66 crore in the quarter ended December 2024 as against Rs 61.67 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 63.66 | 61.67 | 3 |
| OPM % | 6.57 | 0.18 | - |
| PBDT | 4.08 | 0.30 | 1260 |
| PBT | 3.91 | 0.14 | 2693 |
| NP | 2.78 | 0.34 | 718 |
